CVS Health Corporation (NYSE:CVS) traded at around $88 on October 7, up 1.76% on the day and 12.63% higher over twelve months. The Cigna Group (NYSE:CI) traded near $279 over the same session, down 10.56% across the year.
Cigna earns nearly twice the net margin and trades at half the trailing multiple, which makes the share prices the thing to explain.
READ ALSO: Costco (COST) vs Walmart (WMT): Which is a Better Stock to Buy?
The Cheaper Stock Is Also the More Profitable One:
On profitability, the comparison does not go the way the twelve-month returns suggest. Net margin is 2.27% at Cigna against 1.18% at CVS Health. Those are thin figures in absolute terms, which is the permanent condition of a business that pays medical claims.
What matters is the ratio. Cigna keeps almost two dollars of profit for every one CVS Health keeps on the same revenue. Operating margins are nearly identical at 3.98% against 3.86%, so the gap opens below the operating line.
On price, the divergence is wider still, at 11.34 times trailing earnings against 22.73. In January we ranked ten stocks for high returns. The one we put first has returned almost 30% since.
Why the More Expensive Stock Grew Faster:
Earnings grew 191.80% at CVS Health in the most recent quarter against 8.40% at Cigna. A figure that large is a recovery from a weak comparison rather than a new rate of growth, and the forward multiple says so.
CVS Health trades at 10.30 times forward earnings against 22.73 trailing, which is the market pricing the recovery as permanent. Cigna moves much less, from 11.34 times trailing to 8.31 times forward. The balance sheets diverge in the same direction. CVS Health carries $76.31 billion of debt against $31.88 billion.
Current ratios of 0.87 and 0.85 are both below one, so neither company is holding a liquidity cushion.
In May, we ranked this year’s best dividend performers. The one that finished first has since fallen 38%.
The Valuation Case:
CVS Health traded at around $88 on October 7 and is worth $112.49 billion, against $73.59 billion for Cigna. Sustainability for both rests on pharmacy benefit regulation, which is where the current pressure on the industry sits. Book value is $161.62 a share at Cigna against $62.37, which is the larger balance sheet behind the smaller market value.
On price, CVS Health looks cheaper on forward estimates at 10.30 times against 8.31, and dearer on trailing at 22.73 against 11.34. Free cash flow of $11.76 billion at CVS Health against $9.11 billion is the larger company doing roughly what its size implies. The dividends differ in weight. CVS Health yields 3.02% on a 70.00% payout, against 2.24% and 25.38% at Cigna.
Conclusion:
Cigna is the better business on the income statement and the cheaper stock on trailing earnings. A 2.27% net margin against 1.18% and 11.34 times earnings against 22.73 is a consistent set of advantages. However, CVS Health grew earnings 191.80% against 8.40% and produced $11.76 billion of free cash flow, and a forward multiple of 10.30 says the market expects that profit to hold. It carries $76.31 billion of debt to do it. The number to watch is net margin at CVS Health, because 1.18% is the figure the entire forward multiple depends on improving.
Market Sentiment:
CVS Health Corporation was held by 88 hedge funds with a combined stake value of about $7.29 billion at the end of Q2 2026 in the Insider Monkey database. This is up from 84 hedge fund holders with a cumulative investment value of around $4.61 billion in the previous quarter.
The Cigna Group was held by 77 hedge funds with a combined stake value of about $5.28 billion at the end of Q2 2026 in the Insider Monkey database. This is down from 79 hedge fund holders with a cumulative investment value of around $5.01 billion in the previous quarter.
While we acknowledge the risk and potential of CVS and CI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CVS and CI and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: Here is Why Tripadvisor (TRIP) is a Bad Investment at Today’s Price and Costco (COST) vs Walmart (WMT): Which is a Better Stock to Buy?
This article is originally published at Insider Monkey.
